Photodynamic inactivation (PDI) and NO-releasing chitosan nanoparticles (CSNPs) were associated to treat cutaneous leishmaniasis in mice to verify synergism between therapies. Parasite burden, lesion size and hyperalgesia were analyzed. CSNPs were not able to improve PDI.
© 2018 The Author(s)
You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.
Contact your librarian or system administrator
Login to access OSA Member Subscription